濮阳东方医院妇科具体位置在哪濮阳市东方医院在哪个地方,濮阳东方医院男科治早泄收费很低,濮阳东方看男科收费低不低,濮阳东方医院男科治阳痿评价好很专业,濮阳东方医院做人流比较好,濮阳东方男科价格偏低,濮阳东方医院治阳痿价格收费透明

White House chief of staff Mark Meadows told reporters Wednesday that President Donald Trump wants to continue working from the Oval Office despite being infected with COVID-19.According to CNN and CBS, Meadows told reporters that the White House would be taking extra precautions to allow Trump to do so. According to CBS reporter Ben Tracy, any White House staff coming in contact with the president will wear gowns, gloves, masks and eye protection.It's unclear if Trump would also wear personal protective equipment (PPE) while working in the Oval Office.Following Meadows' statement to reporters, Larry Kudlow, the Director of the United States National Economic Council, said during an appearance on CNBC that Trump visited the West Wing with those added precautions on Tuesday.Medical experts say that while PPE greatly reduces the spread of COVID-19, it cannot prevent the spread of the virus entirely. The CDC recommends that anyone who comes within six feet of a person who may have COVID-19 should quarantine for 14 days, excluding those who have had the virus within the last three months.During a press conference on Monday, White House physician Dr. Sean Conley did not specify if Trump would be asked to quarantine in the White House residence while he was infected with COVID-19.This story is breaking and will be updated. 1346

When astronaut Victor Glover climbed aboard the International Space Station early Tuesday morning, he became the first Black astronaut arriving for a long-term stay.Glover, along with his fellow SpaceX Crew Dragon capsule crewmates, will stay on the ISS for six months.A handful of Black astronauts have visited the orbiting lab during space shuttle missions, their stays were a few weeks. More than 300 astronauts from NASA have reached space to date, and Glover is the 15th Black astronaut to do so, according to the New York Times.Glover was selected as an astronaut in 2013, at the time he was serving as a Legislative Fellow in the United States Senate, according to NASA.He is now the pilot and second-in-command on the Crew-1 SpaceX Crew Dragon capsule, named Resilience. While onboard the ISS, he will serve as the Flight Engineer. 847

When he was diagnosed with two autoimmune diseases, Joel Hechler knew he’d be in for a battle. He didn’t realize maybe his toughest one would be with his insurance company.“I think they put the dollars ahead of a patient’s health,” Hechler said. “I don’t think they fully understand the impact the medicine will have on my long-term health and well-being."Hechler suffers from Crohn’s disease and ulcerative colitis, diseases that attack the lining of his digestive tract. Autoimmune conditions like his can’t be cured but, with the right medication, the symptoms can be controlled.  Finding the right medicine can be hard for those suffering from autoimmune diseases. Even if there are scores of drugs on the market, some patients might only respond to one. In Joel’s case, his doctor thought he’d have a better chance trying a drug called Remicade.“I received a letter from my insurance company that denied the Remicade on the basis that I have to try a different drug before I can get to Remicade," Hechler said.Hechler's insurance company, Premera Blue Cross, wouldn’t approve the drug his doctor prescribed because they wanted him to try a cheaper one first.It’s part of a program that health insurers nationwide use called step therapy, requiring that patients try less-costly drugs before “stepping up” to more expensive ones — even if doctors believes the cheaper drug won’t work.Dr. Larry Adler is president of Huron Gastro in Ypsilanti, Michigan and says he spends virtually every day battling insurance companies over step therapy drugs.“They have to fail this medicine first before they get the new drug,” Adler said. “That doesn’t make any sense.”Adler says it's common for patients to get sicker while waiting for step therapy to run its course.In Hechler's case, it took six weeks of fighting with his insurer to convince them that the cheaper drug wouldn’t be effective. As he was waiting, he was getting worse.“It got to the point where I had to be admitted to the hospital,” Hechler said. "I was very, very sick.”Step therapies are used by insurers to try to control skyrocketing prescription medicine costs, says Glen Perry, Director of Pharmacy Contracting and Sales for Blue Cross Blue Shield of Michigan.“These drugs can cost up to 0,000 per year. These are not cheap medications,” Perry said.“It seems like you’re telling patients that, in many cases, your insurer knows what’s best for you, rather than your doctor,” Jones said.“We are trying to provide the most cost effective and safe medication use,” Perry said, adding that when a doctor and insurer disagree over a drug, they can usually resolve the case within a few days without putting a patient at serious risk.“A delay of one or two days I don’t think is really going to make that much of a difference for the medical outcome of the patient," he said.But for many patients, like Phyllis Toole, the delay is longer than a few days.Phyllis suffers from rheumatoid arthritis, a condition where her body attacks her joints. When her doctor wanted to put her on Orencia, her insurance company HAP said she needed to first try a less expensive drug, Humira.But Phyllis’ doctor was worried about possible side effects and thought Humira could be risky.After battling for months, Phyllis says the whole thing made her feel more like a number than a patient. With her doctor and insurer in a standoff, she was forced to rely on samples of the drug she got from her doctor. HAP never approved her prescription.“They’re playing doctor, is what it feels like,” Toole said. “They’re saying this is what you can have for the symptoms you have. It may make you sicker, but this is what you can have.”HAP issued the following statement to Scripps station WXYZ in Detroit: 3800

With millions of Americans getting tested for COVID-19 every single day, some are struggling with long waits for results.But now, researchers say there’s a much easier and faster way to test for the virus, and its right under your nose.“You scratch it, smell it, and then you have a choice of these different windows and you pick which one,” said Derek Toomre, Ph.D., a professor at Yale University School of Medicine.Toomre is part of U-Smell-It, a team that created a scratch-and-sniff app to help determine if someone has COVID-19 all through the sense of smell.“It's going to see how good your sense of smell is and if you do really well, you’ll pass,” Toomre said. “And if you don’t, it will say, ‘hey, you got something up.’”Despite being less accurate than a COVID-19 diagnostic test, this product is much faster and less costly. With results available in less than a minute and the cards costing 50 cents a pop, scientists say this smell app could outperform traditional tests at a fraction of the price.“We’re all familiar with the idea of testing people for fever as a way of finding people who have COVID,” said Roy Parker, Ph.D. a biochemistry professor at the University of Colorado, Boulder. “But that hasn’t worked very well.”Parker says with only about 20% of people with COVID-19 getting a fever, compared to 80% of people with COVID-19 reporting a loss a smell, a smell test is a much better indicator of COVID-19 infection than a temperature check.“It would make a big difference because you would identify people who have COVID, but they have such mild symptoms that they don’t know it and they’re out walking around potentially infecting other people and their family,” Park said.While commercially available, U-Smell-It is now looking for emergency FDA approval with the goal of getting their scratch-and-sniff cards into people’s hands and under their noses as quick as possible.“I can see people saying, ‘hey, this is not serious,’ and that’s fine, don’t take it serious,” Toomre said. “Let’s just try to do it and see if it works. And if you can’t smell that test and it’s saying, ‘hey, there’s something up’ well, you know, you should isolate and check out.” 2192

While we're all focused on COVID-19 as we head back to school this fall, Patti Wukovits is focusing on Meningitis B.“She loved to entertain and make people laugh. She enjoyed life. When I think of Kim the one word that comes to mind is joy,” said Wukovits. It's still painful for Wukovits to talk about her only daughter. Kimberly Coffey was a high school senior who was in her last two weeks of school. She'd been accepted to nursing school and was ready to launch her career. She wanted to follow in her mom's footsteps and be a nurse. One day she came home from school with a fever.“By the next morning she wasn’t fine at all. She said 'mommy everything hurts from my eyelashes to my toes.' This is really, really bad. She couldn’t pull her head off the pillow and was completely lethargic,” Wukovits recounted. Kimberly told her mom that it felt like her ankles were bleeding. Patti saw purple dots and rushed her daughter to the emergency room. “One of the doctors pulled me aside and said 'we believe your daughter had bacterial meningitis.' I said 'That’s not possible. I made sure Kim was vaccinated with the meningitis vaccine.'”She learned that Kim wasn't fully protected. "At the time, in 2012, when she got sick we didn’t have a Meningitis B vaccine in the United States so I couldn’t protect her with that. She didn’t have the privilege of having a Meningitis B vaccine."Doctor Paul Offit, Professor of Pediatrics at Children's Hospital of Philadelphia says it's a vaccine that's necessary and reduces your chances of the type of pain, loss and suffering that Patti lives with everyday.“There’s five different strains that causes these, one vaccine prevents 4 of them: a, c, w, y and then there’s a b category, so 5- A, c, y,w and b. A few of the vaccines just do a c w and y and couple just do b, so 2 vaccines to prevent all 5 strains,” said Dr. Offit. Wukovits says, "her organs were failing and she was in septic shock and she went into cardiac arrest this is a child who was just in her classroom the day before talking with her friends about prom and how her beautiful dress was on her closet door and excited about graduation and starting nursing school.”Out of Kimberly's tragedy - came the Kimberly Coffey Foundation and the Meningitis B Action Project. “I am promoting awareness of her story so that this does not happen to anyone else. It does not have to happen any longer, we have a vaccine and it should not be happening. We shouldn’t lose one more child. But again, if parents don’t know about it we might not know to ask about it,” Wukovits said.Even in the COVID-19 era, Wukovits is doing webinars, educating everyone about the two separate vaccines, and empowering parents and families to have the conversation before they head back to school this fall. “I know we’re making a difference I know that. Kimberly’s dream was to be a pediatric nurse and save children’s lives and this is not how she or I planned she would save children’s lives but she still is and through me. I’m her voice.”A powerful message from a mom on a mission to save lives, just like Kim would have wanted. 3118